On International Day of Women and Girls in Science, meet the female scientists, marine biologists, nanotechnologists, oncologists and professors who are inspiring more women and young girls to pursue careers in science and technology
Despite progress in closing the gender gap in science, disparities remain. Unesco reports that only one in three scientists worldwide is a woman, fewer than two in five STEM graduates are female and just 12 per cent of national academies of science members are women. Today, on the International Day of Women and Girls in Science, the call to action is clearer than ever: eliminate barriers to women’s participation in science, increase investment in science education for women and girls and amplify the visibility of female role models in STEM.
Across Asia, accomplished women in science are not only advancing their fields but also inspiring the next generation. From Dr Ho Weang Kee, who is revolutionising breast cancer risk assessment, to Dr Ho Thi Thanh Van, who is pioneering clean energy solutions, these trailblazers from Asia’s Most Influential prove that women are not just participating in science—they are leading it.
Their achievements pave the way for a more inclusive and innovative scientific community, one where future generations of women will not only follow in their footsteps but forge new paths as marine biologists, nanotechnologists, medical doctors, researchers and more.
Also read: Asia’s big tech giants spearheading the next digital wave
Judith Swain, chief medical officer, PhysioWave (Singapore)

With a career spanning over five decades, Judith Swain has influenced medical research and clinical practice, particularly in the field of cardiology. The molecular cardiologist and physician-scientist serves as the chief medical officer of PhysioWave, the firm founded by Stanford researchers to help prevent premature death caused by heart disease. To assess cardiovascular risk, for example, the company’s PhysioWave Pro scale measures aortic stiffness, assessing how pressure, blood flow and arterial diameter change with each heartbeat.
Beyond her role at the firm, Swain expands her influence on public health, serving on the boards of Lexicon Pharmaceuticals, the Lee Kong Chian School of Medicine and Upstream Medical Technologies.